UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GLCNF, GLNCY, MD, and UNM


NEW YORK, July 16, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Glencore plc (OTCMKTS:GLCNF) (OTCMKTS:GLNCY)
Lead Plaintiff Deadline: September 7, 2018
Class Period: September 30, 2016 and July 2, 2018

Allegations: Glencore’s conduct would subject it to heightened scrutiny by U.S. and foreign government bodies resulting in investigations into the company’s compliance with money laundering and bribery laws, as well as the Foreign Corrupt Practices Act; and as a result, defendants’ statements about Glencore’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

On May 18, 2018, Bloomberg reported that the U.K.'s Serious Fraud Office was preparing to open a formal bribery investigation into Glencore. Then on July 3, 2018, Glencore disclosed that the U.S. Department of Justice issued its subsidiary a subpoena to produce documents and other records in connection with its compliance with U.S. money laundering statutes and the Foreign Corrupt Practices Act.

Get additional information about GLCNF: http://www.kleinstocklaw.com/pslra-c/glencore-plc?wire=3.

MEDNAX, Inc. (NYSE:MD)
Lead Plaintiff Deadline: September 7, 2018
Class Period: February 4, 2016 and July 27, 2017

Allegations: the Company's business model was not sustainable; and Mednax's growth was in fact based upon suppressing physician compensation and enforcing non-compete agreements to deter physician defections.

On April 20, 2017, Mednax announced negative financial results for the first quarter of 2017. Then on July 28, 2017, during an earnings call, Mednax announced that the Company failed to complete any acquisitions of anesthesiologist practices during the second quarter and disclosed that any future acquisitions were unlikely. Following this news, shares of Mednax fell from a close of $56.49 on July 27, 2017, to a close of $47.73 per share the following day.

Get additional information about MD: http://www.kleinstocklaw.com/pslra-c/mednax-inc?wire=3.

Unum Group (NYSE:UNM)
Lead Plaintiff Deadline: August 13, 2018
Class Period: January 31, 2018 and May 2, 2018

Allegations: The Company was experiencing a higher claims incidence for its long-term care business; the Company was experiencing less favorable policy terminations in connection with its long-term care business; as such, the Company’s long-term care business loss ratio would reach the upper 90% range; and as a result of the foregoing, Defendants’ statements about Unum’s business, operations, and prospects, including statements related to the Company’s long-term care reserves and capital management plans, were materially false and/or misleading and/or lacked a reasonable basis.

Get additional information: http://www.kleinstocklaw.com/pslra-c/unum-group?wire=3.

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
                                                            
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com